Skip to main content

Table 9 Death due to bleeding by predicted risk at baseline

From: The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial

Risk decilea Tranexamic acid (TXA) Placebo Risk ratio (95 % CI)
  Death due to bleeding Received TXA Death due to bleeding Received placebo  
1 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
2 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
3 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
4 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
5 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
6 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
7 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
8 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
9 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
10 NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
Overall NN (X %) N NNN NN (X %) N NNN X.XX (X.XX–X.XX)
(I 2 = X %, p = 0.XX)      
  1. Notes
  2. aDeciles of the predicted risk of the outcome at baseline, using a prognostic model including the baseline variables maternal age, estimated blood loss, systolic blood pressure and haemodynamic instability